Multiple system atrophy (MSA) is a sporadic and rapidly progressive neurodegenerative
disorder that presents with autonomic failure in combination with parkinsonism or cerebellar …

Multiple system atrophy (MSA) is a fatal, rapidly progressing neurodegenerative disease of
uncertain etiology, clinically characterized by various combinations of Levodopa …

Multiple system atrophy (MSA) is a sporadic neurodegenerative disorder that usually
manifests in the early sixth decade of life and progresses relentlessly with a mean survival of 9 …

… According to the updated Movement Disorder Society diagnostic criteria for multiple
system atrophy, the diagnosis of clinically established multiple system atrophy requires the …

Multiple systemic atrophy (MSA) is a progressive, adult-onset neurodegenerative disorder
of undetermined aetiology characterized by a distinctive oligodendrogliopathy with …

Multiple system atrophy (MSA) is a fatal, adult-onset neurodegenerative disorder of
uncertain etiology, clinically characterized by various combinations of Levo-dopa-unresponsive …

… atrophy in multiple system atrophy using fluid-registered MRI. Coronal MRI scan with
voxel-compression-mapping overlay to demonstrate areas undergoing atrophy. Greatest rates of …

… Possible prodromal multiple system atrophy has been introduced as a category in the
updated diagnostic criteria, for research purposes. This new category acknowledges that, years …

While cognitive impairment, which was previously considered a red flag against the clinical
diagnosis of multiple system atrophy (MSA), is a common symptom of this rare …

… Multiple system atrophy (MSA) may be difficult to distinguish clinically from other disorders,
particularly in the early stages of the disease. An autonomic-only presentation can be …